Form 4 for ENTA ENANTA PHARMACEUTICALS INC
Accepted 2023-04-19 00:00:00 ET · period of report 2023-04-18 · accession 0001062993-23-009374 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-19 | 2023-04-18 | ENTA | Gardiner Nathaniel S. | SVP, GC | M - OptEx | $30.00 | +6,667 | 80.0K | +9% | +$200.0K |
| D | 2023-04-19 | 2023-04-18 | ENTA | Gardiner Nathaniel S. | SVP, GC | M - OptEx | $0.00 | -6,667 | 7,000 | -49% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-18 | M | A | 6,667 | $30.00 | 79,980 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-04-18 | M | D | 6,667 | $0.00 | 7,000 | D | $30.00 · — to 2026-11-18 | 6,667 Common Stock | (F2) 100% of the shares subject to the option are fully vested and exercisable. |